[VRTX] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
14-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- 335.14%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 6,205,683 4,162,821 3,047,597 2,488,652 1,702,177 1,032,336 580,415 48.37%
PBT 3,116,798 1,394,919 600,241 -15,689 -67,366 -559,581 -734,875 -
Tax 405,151 218,109 -1,486,862 -107,324 16,665 30,381 6,958 96.75%
NP 2,711,700 1,176,810 2,096,896 263,484 -112,052 -558,115 -738,555 -
Tax Rate -13.00% -15.64% 247.71% - - - - -
Total Cost 3,493,983 2,986,011 950,701 2,225,168 1,814,229 1,590,451 1,318,970 17.61%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 43.70 28.27 68.80 10.59 -6.58 -54.06 -127.25 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 10.44 4.58 8.25 1.06 -0.46 -2.32 -3.14 -
EPS Diluted 10.29 4.51 8.09 1.04 -0.46 -2.31 -3.14 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.